Latest News about top stories
Recent news which mentions top stories
Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of Revumenib In Form Of Blood Cancer
November 12, 2024
From Benzinga
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
November 12, 2024
From Benzinga
Stocks Fall On Tariffs Fears, Dollar Hits 6-Month Peak, Yen Tumbles: What's Driving Markets Tuesday?
November 12, 2024
From Benzinga
What's Going On With Sidus Space Today? New Partnership With Lonestar Bodes Well For Stock
November 12, 2024
From Benzinga
iHeartMedia Announces Debt Restructuring, Analyst Turns Bullish And Raises Forecast
November 12, 2024
Tickers
IHRT
From Benzinga
What's Going On With US-Listed Chinese Stocks Trading Lower On Tuesday?
November 12, 2024
From Benzinga
Chipotle's New Boss: Can CEO Scott Boatwright Spice Up CMG?
November 12, 2024
From Benzinga
Russell 2000 Rallies, JPMorgan Analyst Says Small Cap May Outperform Mega-Cap Peers
November 12, 2024
From Benzinga
The German Government Sold Its Bitcoin—Here's How Much It Missed Out On
November 12, 2024
From Benzinga
Why Medical Device Firm Nevro Stock Is Trading Higher On Tuesday
November 12, 2024
From Benzinga
From Benzinga
Neurogene Stock Tanks After Adverse Event In Early-Stage Rett Syndrome Gene Therapy Trial
November 12, 2024
From Benzinga
EXCLUSIVE: Chris Christie Says Trump Will Remove Federal Restrictions On Marijuana, Find 'Sweet Spot' For Crypto Regulation
November 12, 2024
Tickers
NEWS
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.